Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.

Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found